Cello Therapeutics
Nanotechnology, 5945 Pacific CTR BLVD, San Diego, California, 92121, United States, 1-10 Employees
Phone Number: 85********
Who is CELLO THERAPEUTICS
Cello Therapeutics, Inc. (Cello) was founded in April 2016 and specializes in the development of nanoparticles for cancer treatment. Our nanoparticles are composed of FDA-approved cancer ...
Read More
-
Headquarters: 5945 Pacific CTR BLVD, San Diego, California, 92121, United States
-
Date Founded: 2016
-
Employees: 1-10
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
-
CEO:
Jie Zhang
Email
Phone
Industry: Nanotechnology
Does something look wrong? Fix it. | View contact records from CELLO THERAPEUTICS
Cello Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Cello Therapeutics
Answer: Cello Therapeutics's headquarters are located at 5945 Pacific CTR BLVD, San Diego, California, 92121, United States
Answer: Cello Therapeutics's phone number is 85********
Answer: Cello Therapeutics's official website is https://cellotherapeutics.com
Answer: Cello Therapeutics's revenue is $1 Million to $5 Million
Answer: Cello Therapeutics has 1-10 employees
Answer: Cello Therapeutics is in Nanotechnology
Answer: Cello Therapeutics contact info: Phone number: 85******** Website: https://cellotherapeutics.com
Answer: Cello Therapeutics, Inc. (Cello) was founded in April 2016 and specializes in the development of nanoparticles for cancer treatment. Our nanoparticles are composed of FDA-approved cancer drugs loaded within a biocompatible polymer core. These nanoparticles are then coated with natural red blood cell membrane, a recent breakthrough technology in the field of nanomedicine. Appearing as red blood cells to the body, these membrane-coated nanoparticles are able to avoid evoking an immune response while circulating in the bloodstream for an extended period of time for improved drug delivery to tumor sites. With this novel approach to cancer treatment, our products offer unique performance advantages for oncological applications. Currently, the company is in the drug development and testing stage. Cello Therapeutics, Inc. licenses technology and laboratory protocols for nanoparticle development from its parent company, Arytha Biosciences, LLC. Cello also benefits from the efforts of its sibling company, Cellics Therapeutics, Inc., which specializes in developing nanoparticles for biodetoxification and the treatment of infectious diseases, and provides engineering expertise in membrane-coating technology.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month